← Back to guidelines
Cardiology109 papers

Staphylococcus aureus meningitis

Last edited: 4/14/2026

Overview

Staphylococcus aureus meningitis is a severe infection of the central nervous system caused by S. aureus, often associated with high morbidity and mortality rates. Prompt and appropriate management is crucial for improving outcomes 125.

Diagnosis

  • Positive cerebrospinal fluid (CSF) culture identifying S. aureus
  • Elevated CSF white blood cell count and protein levels
  • Lumbar puncture essential for definitive diagnosis 5
  • Management

  • First-line treatment: Intravenous antibiotics (e.g., vancomycin, adjusted based on susceptibility) 15
  • Adjunctive therapies: Dexamethasone may be considered to reduce inflammation and improve outcomes, though evidence varies 5
  • Duration: Typically 2-4 weeks, adjusted based on clinical response and CSF culture results 5
  • Source control: Essential for managing any underlying focus of infection (e.g., shunt infection, subdural empyema) 35
  • Special Populations

  • Elderly: Higher risk of complications and mortality; close monitoring and multidisciplinary care recommended 23
  • Comorbidities: Patients with cirrhosis or those requiring ICU admission early post-diagnosis have increased mortality risk 5
  • Key Recommendations

  • Initiate intravenous antibiotic therapy promptly for S. aureus meningitis, tailored to susceptibility results (Evidence: Strong 15)
  • Consider infectious diseases consultation to improve adherence to evidence-based management and potentially enhance long-term outcomes (Evidence: Moderate 35)
  • Emphasize source control in the management plan to reduce mortality and improve recovery (Evidence: Moderate 35)
  • Monitor closely for high-risk patients, particularly those with advanced age or comorbidities, to mitigate increased mortality risk (Evidence: Moderate 235)
  • References

    1 Mourad A, Nwafo N, Skalla L, Holland TL, Jenkins TC. Oral Versus Intravenous Antibiotic Therapy for Staphylococcus aureus Bacteremia or Endocarditis: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2025. link 2 Bai AD, Lo CKL, Komorowski AS, Suresh M, Guo K, Garg A et al.. Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2022. link 3 Goto M, Jones MP, Schweizer ML, Livorsi DJ, Perencevich EN, Richardson K et al.. Association of Infectious Diseases Consultation With Long-term Postdischarge Outcomes Among Patients With Staphylococcus aureus Bacteremia. JAMA network open 2020. link 4 Liu C, Strnad L, Beekmann SE, Polgreen PM, Chambers HF. Clinical Practice Variation Among Adult Infectious Disease Physicians in the Management of Staphylococcus aureus Bacteremia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019. link 5 Honda H, Krauss MJ, Jones JC, Olsen MA, Warren DK. The value of infectious diseases consultation in Staphylococcus aureus bacteremia. The American journal of medicine 2010. link 6 Nagao M, Iinuma Y, Saito T, Matsumura Y, Shirano M, Matsushima A et al.. Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2010. link

    Original source

    1. [1]
      Oral Versus Intravenous Antibiotic Therapy for Staphylococcus aureus Bacteremia or Endocarditis: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials.Mourad A, Nwafo N, Skalla L, Holland TL, Jenkins TC Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2025)
    2. [2]
      Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis.Bai AD, Lo CKL, Komorowski AS, Suresh M, Guo K, Garg A et al. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases (2022)
    3. [3]
      Association of Infectious Diseases Consultation With Long-term Postdischarge Outcomes Among Patients With Staphylococcus aureus Bacteremia.Goto M, Jones MP, Schweizer ML, Livorsi DJ, Perencevich EN, Richardson K et al. JAMA network open (2020)
    4. [4]
      Clinical Practice Variation Among Adult Infectious Disease Physicians in the Management of Staphylococcus aureus Bacteremia.Liu C, Strnad L, Beekmann SE, Polgreen PM, Chambers HF Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2019)
    5. [5]
      The value of infectious diseases consultation in Staphylococcus aureus bacteremia.Honda H, Krauss MJ, Jones JC, Olsen MA, Warren DK The American journal of medicine (2010)
    6. [6]
      Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia.Nagao M, Iinuma Y, Saito T, Matsumura Y, Shirano M, Matsushima A et al. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases (2010)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG